TF and hydrops fetalis: Randomized trials of intravenous iron supplementation in patients with HF have shown that intravenous iron supplementation demonstrates significant prognostic benefits in patients with serum transferrin saturation <20% and may have deleterious consequences in patients with transferrin saturation >24%109.